UBS AG (EPT) Form 8.5 (EPT/RI) - Mediclinic Amendment (5020A)
May 24 2023 - 5:00AM
UK Regulatory
TIDMMDC
RNS Number : 5020A
UBS AG (EPT)
24 May 2023
This announcement replaces the previous RNS announcement 3709A
released at 11:21 on the 23(rd) May 2023. Amendments to sections 2a
and 2b. All other information remains unchanged.
FORM 8.5 (EPT/RI)
PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH
RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING
CAPACITY
Rule 8.5 of the Takeover Code (the Code)
1. KEY INFORMATION
(a) Name of exempt principal trader: UBS Investment Bank, London
(b) Name of offeror/offeree in relation to whose relevant securities this Mediclinic International plc
form relates:
Use a separate form for each offeror/offeree
----------------------------------------
(c) Name of the party to the offer with which exempt principal trader is Mediclinic International plc
connected:
----------------------------------------
(d) Date dealing undertaken: 22 May 2023
----------------------------------------
(e) In addition to the company in 1(b) above, is the exempt principal NO
trader making disclosures
in respect of any other party to this offer?
If it is a cash offer or possible cash offer, state "N/A"
----------------------------------------
2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER
Where there have been dealings in more than one class of
relevant securities of the offeror or offeree named in 1(b), copy
table 2(a), (b), (c) or (d) (as appropriate) for each additional
class of relevant security dealt in.
The currency of all prices and other monetary amounts should be
stated.
(a) Purchases and sales
Class of relevant Purchases/ sales Total number of Highest price per unit Lowest price per unit
security securities paid/received paid/received
10p ordinary Buy 146950 5.00500 4.95580 GBP
GBP
----------------- ------------------------ ----------------------- -----------------------
10p ordinary Sell 108402 5.00500 4.95580 GBP
GBP
----------------- ------------------------ ----------------------- -----------------------
(b) Cash-settled derivative transactions
Class of relevant Product description Nature of dealing Number of reference Price per unit
security e.g. CFD e.g. opening/closing a securities
long/short position,
increasing/reducing a
long/short position
10p ordinary CFD Long 19000 4.997684 GBP
-------------------- ----------------------- ----------------------- ---------------------
10p ordinary CFD Long 1204 5.0 GBP
-------------------- ----------------------- ----------------------- ---------------------
10p ordinary CFD Long 7840 5.005 GBP
-------------------- ----------------------- ----------------------- ---------------------
10p ordinary CFD Long 23562 118.5184 ZAR
-------------------- ----------------------- ----------------------- ---------------------
10p ordinary CFD Long 6284 5.002327 GBP
-------------------- ----------------------- ----------------------- ---------------------
10p ordinary CFD Long 162 5.000000 GBP
-------------------- ----------------------- ----------------------- ---------------------
10p ordinary CFD Short 86604 5.00290044339753 GBP
-------------------- ----------------------- ----------------------- ---------------------
10p ordinary CFD Short 833 5.005 GBP
-------------------- ----------------------- ----------------------- ---------------------
10p ordinary CFD Short 23562 118.5184 ZAR
-------------------- ----------------------- ----------------------- ---------------------
10p ordinary CFD Short 1049 5.00289799809342 GBP
-------------------- ----------------------- ----------------------- ---------------------
10p ordinary CFD Short 8688 5.0035508747698 GBP
-------------------- ----------------------- ----------------------- ---------------------
(c) Stock-settled derivative transactions (including options)
(i) Writing, selling, purchasing or varying
Class of Product Writing, Number of Exercise Type Expiry date Option money
relevant description purchasing, securities price per e.g. paid/
security e.g. call selling, to which unit American, received per
option varying etc. option European unit
relates etc.
(ii) Exercise
Class of relevant Product description Exercising/ exercised Number of securities Exercise price per
security e.g. call option against unit
(d) Other dealings (including subscribing for new securities)
Class of relevant security Nature of dealing Details Price per unit (if applicable)
e.g. subscription, conversion
3. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
Details of any indemnity or option arrangement, or any agreement or understanding, formal
or informal, relating to relevant securities which may be an inducement to deal or refrain
from dealing entered into by the exempt principal trader making the disclosure and any party
to the offer or any person acting in concert with a party to the offer:
Irrevocable commitments and letters of intent should not be included. If there are no such
agreements, arrangements or understandings, state "none "
None
(b) Agreements, arrangements or understandings relating to options or derivatives
Details of any agreement, arrangement or understanding, formal or informal, between the exempt
principal trader making the disclosure and any other person relating to:
(i) the voting rights of any relevant securities under any option; or
(ii) the voting rights or future acquisition or disposal of any relevant securities to which
any derivative is referenced:
If there are no such agreements, arrangements or understandings, state "none"
None
Date of disclosure: 24 May 2023
Contact name: Richard Howard
--------------------
Telephone number: +44 (0)207 568 9128
--------------------
Public disclosures under Rule 8 of the Code must be made to a
Regulatory Information Service and must also be emailed to the
Takeover Panel at monitoring@disclosure.org.uk
The Panel's Market Surveillance Unit is available for
consultation in relation to the Code's dealing disclosure
requirements on +44 (0)20 7638 0129.
The Code can be viewed on the Panel's website at
www.thetakeoverpanel.org.uk .
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
FERNKQBQFBKKCPB
(END) Dow Jones Newswires
May 24, 2023 06:00 ET (10:00 GMT)
Mediclinic (LSE:MDC)
Historical Stock Chart
From Nov 2024 to Dec 2024
Mediclinic (LSE:MDC)
Historical Stock Chart
From Dec 2023 to Dec 2024
